(pressebox) Magdeburg, 15.04.2009, IMTM announced that it has been granted two patents covering the PETIR(TM) technology platform by the US Patent Office and one additional patent of dual PETIR(TM) prodrugs by the European Patent Office. The US patents protect the company rights of PETIR(TM) based therapy for the treatment of autoimmune diseases and transplant rejection [...]
↧